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E-mail address: Julien.Limenitakis@unige.ch (J. LimThe Apicomplexans are obligate intracellular protozoan parasites and the causative agents of severe
diseases in humans and animals. Although complete genome sequences are available since many
years and for several parasites, they are replete with putative genes of unassigned function. Forward
and reverse genetic approaches are limited only to a few Apicomplexans that can either be propa-
gated in vitro or in a convenient animal model. This review will compare and contrast the most
recent strategies developed for the genetic manipulation of Plasmodium falciparum, Plasmodium
berghei and Toxoplasma gondii that have taken advantage of the intrinsic features of their respective
genomes. Efforts towards the improvement of the transfection efﬁciencies in malaria parasites, the
development of approaches to study essential genes and the elaboration of high-throughput meth-
ods for the identiﬁcation of gene function will be discussed.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The phylum Apicomplexa encompasses more than 5000 species
of intracellular parasites, many of which are important pathogens
for humans and animals. In recent years, many apicomplexan gen-
omes have been sequenced, including those of the malaria species
Plasmodium falciparum [1], Plasmodium vivax [2], Plasmodium
berghei [3], Plasmodium yoelii [4], and Plasmodium knowlesi [5]. The
genomes of two additionalmembers of the haemosporidia, Theileria
parva [6] and Babesia bovis [7], which infect the red blood cells of
vertebrates during their life cycle, have been shown tobe interesting
sources for comparison. The group of more distantly related cocci-
dian parasites that have been sequenced includes Toxoplasma gondii
[8], Neospora caninum [8], Eimeria tenella (www.genedb.org),
Cryptosporidium parvum [9] and Cryptosporidium hominis [10].
P. falciparum is responsible for the most severe form of malaria,
whereas P. vivax, themost widespread humanmalaria parasite out-
side of sub-Saharan Africa, causes a disease prone to relapse from a
dormant formcalledhypnozoite [11]. Theclosely related rodentpar-
asites, P. berghei and P. yoelii, and the primate parasite, P. knowlesi,
allow investigations of parasite–host cell interactions in vivo and
provide access to material for studies of parasite stages from
mosquitoes and from host livers. Rodent malaria parasiteschemical Societies. Published by E
enitakis).constitute the model of choice for studying gene function in vivo
[12]. Other Apicomplexans are important opportunistic pathogens.
In patients suffering from AIDS, T. gondii can cause toxoplasmosis
encephalitis, and C. parvum can lead to severe enteritis. T. gondii is
a cyst-forming parasite found in virtually all warmblooded animals.
It is chronically established in one-third of the human population,
usually as a result of ingesting contaminated meat. This makes this
protozoan one of the most successful parasites [13]. Some other
coccidian parasites are of considerable veterinary importance, such
as E. tenella, responsible for devastating disease in poultry, and
N. caninum, which causes chronic infections in dogs and abortion
in cattle. Other severe cattle infections are caused by T. parva,
transmitted by a tick-bite and responsible for the so-called East
Coast fever, and themosquito-transmitted B. bovis, which is respon-
sible for babesiosis in tropical and semi-tropical areas. Despite the
considerable advances conferred by large-scale genome sequencing
and various global transcriptomic and proteomic studies, assign-
ment of gene functions remains limited in Apicomplexans. In the
case of the well-studied organism P. falciparum, the frequency of
identiﬁed open reading frames (ORFs) not assigned to any known
function has dropped from 60% at the publication of the genome
[1] to just below 50% a decade later [14].
A survey of the other apicomplexan genomes available through
EupathDB [8] shows a higher frequency of ‘hypothetical genes’. This
ﬁnding is partly explained by the inability to propagate some
apicomplexan parasites in tissue culture, which makes them lesslsevier B.V. All rights reserved.
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cated by extended sequence divergence compared to other organ-
isms. This is particularly the case for the early divergent
Apicomplexan,C. parvum, forwhichputative functionswere initially
assigned to only 4% of the predicted ORFs [9]. Undoubtedly compar-
ative genomics, transcriptomics and proteomics will continue to
provide more information about the so-called ‘hypothetical pro-
teins’, but the identiﬁcation of unique parasite functions ultimately
relies heavily on genetic approaches. Reverse genetics, which con-
sists of altering or deleting a gene to unravel its biological function,
harnesses information from sequenced genomes and is a favoured
approach for analysing parasite gene functions. In contrast, forward
genetics seeks to identify the gene(s) responsible for a particular
phenotype and is often a less trivial and more time-consuming ap-
proach. To identify the gene responsible for a given phenotype, sev-
eral options can be utilised. Forward genetic mapping has been
successfully used to identify genes such as those responsible for nat-
ural differences in T. gondiivirulence [15] or for resistance todrugs in
the malaria parasites [16]. Genome wide quantitative trait locus
(QTL) mapping was shown to be a powerful method to analyse the
genetic basis of a speciﬁc trait in the progeny from genetic crosses
between parental strains that differ with respect to a given pheno-
type. Alternatively, gene identiﬁcation canbeachievedby functional
complementation with cDNA or even better with cosmid libraries
that circumvent the inherent redundancy of cDNA libraries [17].
More recently, the power of large scale genome sequencing and
analysis offers a new solution to the problem [18].
Of the approximately 5000 genes in P. berghei, 458 (as of Febru-
ary 2011) have been analysed using reverse genetics and reported
in a database (www.pberghei.eu). This source of information is up-
dated weekly with the latest data from Medline searches and with
unpublished results from various laboratories working on geneti-
cally modiﬁed rodent malaria parasites [19]. This database is an
invaluable tool for researchers. It contains data on genes whose
knockout results in abnormal phenotypes and key negative results,
such as failure to generate knockouts or knockouts that exhibited
no phenotype based on classic assays. Previously, such data have
been absent from the public domain, which is biased towards the
reporting of knockouts with strong and clear phenotypes. Similar
databases would be beneﬁcial for P. falciparum and T. gondii, as sug-
gested in [20].
To increase the number of genes that are assessed functionally,
it is necessary to move from a gene-by-gene method to a large-
scale strategy based on high-throughput approaches. Moreover,
as many genes are essential for parasite survival, there is an urgent
need to develop and optimise strategies for conditional gene
expression controlled at the transcriptional, post-transcriptional
or even post-translational levels.
Previous reviews have described in detail the tools available for
genetic manipulation in apicomplexan parasites [21,22]. This re-
view ﬁrst compares the genetic features of different Apicomplex-
ans and explains their impact on the accessibility to the panoply
of genetic tools. Second, we will address recent developments that
have arisen since the aforementioned reviews and have promoted
gene function analysis in P. falciparum, P. berghei and T. gondii. Pro-
gress in developing large-scale strategies in the form of chemical
and genetic screens and various approaches to controlling gene
expression will be presented.2. Parasite accessibility and limits to genetic manipulation
2.1. The malaria parasites
The speciﬁcities of parasite propagation in hosts are critical to
their accessibility to genetic manipulation. The malaria parasitesexhibit a complex life cycle involving the intermediate host (hu-
man) and the deﬁnitive host (female anopheles), which also serves
as the vector for transmission. The asexual stages in humans have a
haploid genome, which facilitates the generation of mutants. The
erythrocytic stages are used as the source for genetic manipulation.
The cycle is continuously maintained in culture in the case of P.
falciparum, whereas a single round can be passaged in vitro for P.
berghei, which is otherwise maintained in rodents. The continuous
culture of parasites remains a challenge for P. vivax because its
restriction to reticulocytes for invasion considerably complicates
its maintenance in vitro. Several groups are currently developing
procedures for culturing P. vivax in vitro using stem cell technolo-
gies to allow production of reticulocytes and hopefully will render
this parasite accessible to transfection [23].
Critical parameters for successful genetic manipulation are the
ability of the exogenous DNA to access the parasite nucleus and
cell survival. P. falciparum erythrocytic stages have been transfec-
ted while inside red blood cells due to the inability to collect free,
viable merozoites. Introduction of DNA molecules into cells can be
achieved by chemical-based methods or biolystic particle delivery;
however, in Apicomplexans, the most robust and reproducible re-
sults have been obtained using electroporation. The poor transfec-
tion efﬁciencies, in the range of 106 for P. falciparum, are probably
due to the relative inaccessibility of the parasite within the red
blood cell [24]. A recent protocol has been developed for the re-
lease of viable free merozoites for invasion studies [25], and it is
hoped that this methodology will enhance the efﬁciency of trans-
fection. In P. berghei, schizonts matured in vitro are puriﬁed prior
to transfection and are returned to the animal for cultivation and
drug selection. Since the development of nucleofection by Amaxa
and its optimisation for P. berghei, much higher frequencies of
transfection can be achieved [26]. It is thought that this method
produces square wave pulses that enhance pore-formation and
do not require cell division for incorporation of DNA into the nu-
cleus. The Amaxa system also offers the advantage of requiring
smaller amounts of DNA than other techniques [27].
The Plasmodium species exhibit a strongly biased A/T-rich gen-
ome [28]. The A/T richness ranges from 79.6% (P. falciparum) or
67.7% (P. vivax) in protein coding sequences to more than 90% in
intergenic regions of the genomes [1,4]. Other non-Plasmodium api-
complexan genomes do not present such a bias towards A/T rich-
ness. In P. falciparum, the high A/T content also coincides with low
complexity regionswithin ORFs [28]. It remains unknownwhy Plas-
modium bears such low complexity regions within protein coding
sequences, although these sequences often code for aminoacids that
are oriented towards the external surfaces of proteins after folding
and do not interfere with function [29]. It has been hypothesised
that these sequences could be decoys for antibodies and help im-
mune evasion by the parasite [28,30]. Such regions are also more
prone to recombination [31] and could facilitate rapid evolution of
parasite populations. For researchers, such A/T richness renders
Plasmodium DNA highly unstable in Escherichia coli, which hampers
the generation of large plasmids for transfection [32]. If overexpres-
sed or expressed at an inappropriate time, the products of trans-
genes can cause deleterious effects or artefacts affecting their
localisation [33]. This phenomenon is especially relevant for the
Plasmodium species in which transcriptome analysis has revealed
waves of transcripts that are tightly regulated throughout the intra-
erythrocytic cycle [34]. In this respect, the constitutive promoter for
P. berghei, eIF1a, is frequently used to drive expression of exogenous
genes andmayunder somecircumstances, and in conjunctionwith a
long half-life of the expressed protein, result in inaccurate observa-
tions or even parasite lethality.More recently, a series of tightly reg-
ulated stage-speciﬁc promoters has been described and exploited to
control transgene expression. The circumsporozoite protein (CS)
promoter is active in oocysts and sporozoites, while the promoter
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and during development in the mammalian liver [35]. More
recently, a promoter of thePB103464.00.0 genewith tight liver stage
speciﬁcityhasbeendescribed [36]. This promoter couldbeexploited
to drive, in a stage-speciﬁc fashion, the expression of a Flp recombi-
nase with the aim to achieve conditional mutagenesis leading to
gene deletion as discussed below [35]. Reverse genetics in Plasmo-
dium has also been hampered by the limited number of practical
markers for selection of stable transformants. Emergence of natural
resistance to adrugor the toxicityof thedrug for thehost cells or ani-
mals accounts for the need for new markers. Pyrimethamine-resis-
tant dihydrofolate reductase-thymidylate synthase (DHFR-TS), an
enzyme of folate metabolism, is routinely used in Plasmodium spe-
cies as a selectablemarker [37]. In P. berghei, a T. gondii DHFR-TS gene
is mainly used for this selection. It confers resistance to pyrimeth-
amine, which can be supplied effectively in the drinking water of
mice. In P. falciparum, the human DHFR gene is usually used, and it
confers resistance to WR99210 and pyrimethamine [38]. Although
WR99210 can also be used for P. berghei together with the human
DHFRgene, this compoundhasbeenassociatedwithgastrointestinal
intolerance [39] and hence requires to be delivered daily by subcu-
taneous injection in mice. Fungal blasticidin S deaminase (BSD) and
bacterial neomycin phosphotransferase II (NEO) have also been
adapted for P. falciparum [40]; however, cases of resistance to blas-
ticidin have been reported [41]. Dihydroorotate dehydrogenase
(DHOD), an enzyme of the pyrimidine biosynthesis is essential for
malaria parasites due to the absence of salvage pathway for pyrim-
idines [42]. PfDHOD isdependentonubiquinone regenerationby the
mitochondrial electron transport chain (mtETC). The ectopic expres-
sion of Saccharomyces cerevisiaeDHOD,whichdonot require ubiqui-
none as an electron acceptor in P. falciparum established that
parasite survival in the absence of mtETC (in presence of atovaqu-
one) depends only on pyrimidine biosynthesis [42]. ScDHOD has
been successfully used as anewselectablemarker gene for P. falcipa-
rum [43]. The shortage of selectivemarker genes canbeovercomeby
recycling themusing site-speciﬁc recombinases, as ﬁrst exempliﬁed
for T. gondiiwith the Cre/LOX system [44]. This strategy has recently
been adapted tomalaria parasites using the Flp/FRT [45,46] and Cre/
Lox [45] systems. A panoply of reporter genes is listed in Table 1. It
includes ﬂuorescent proteins that can be selected by FACS analysis
and genes that have been utilised to dissect various aspects of para-
site development and host–parasite interactions (reviewed in [47]).
The fate of the DNA introduced into a given parasite is a deter-
minant of the type of reverse genetic tools that can be applied.
Plasmodium species have the ability to maintain plasmids carrying
transgenes as stable episomes, while integration into the genome
occurs almost exclusively by homologous recombination. In P. fal-
ciparum, these plasmids or extrachromosomal replicons are main-
tained in a concatemeric form [48,49]. This phenomenon is not
well suited for knocking out genes by homologous recombination
and requires additional steps of drug cycling to eliminate the epi-
somes. In P. berghei, linearised plasmids integrate into the genome
by an ends-out/replacement mechanism [12] and recombination
frequency is positively correlated with the length of the homology
arms in the construct (Billker, pers. communication). In P. falcipa-
rum, negative selection based on the thymidine kinase (TK) of
the herpes simplex virus (HSV) has been used successfully [50].
In this strategy, the positive selection cassette is ﬂanked by se-
quences homologous to regions upstream and downstream of the
target gene, while the TK gene is positioned elsewhere on the plas-
mid. Under ganciclovir treatment, parasites expressing TK episom-
ally, or after single integration of the plasmid, are poisoned by
competitive inhibition of dGTP incorporation into DNA during rep-
lication, whereas double homologous recombination events lead to
loss of TK and survival of the parasites. Another negative selection
has also been developed for P. falciparum, based on the conversionof an innocuous compound, 5-ﬂuorocytosine (5-FC) into a toxic
one, 5-ﬂuorouracil (5-FU) by S. cerevisiae cytosine deaminase/ura-
cil phosphoribosyl transferase [51]. Integration can also be fa-
voured by recombination between phage Attp sites ﬂanking the
gene of interest and an Attb site previously inserted into the gen-
ome. The recombination is mediated by a mycobacteriophage
bxb1 integrase transiently expressed on a helper plasmid [52].
The tendency of transfected plasmids to persist as episomes in
the malaria parasites is unfavourable for the isolation of parasites
that underwent genome integration events but in counterpart, this
property can be exploited to generate artiﬁcial chromosomes that
serve as useful tool for gene transfer [53].
2.2. The model organism T. gondii
T. gondii belongs to another branch of the phylum that includes
the cyst-forming coccidians. This ubiquitous parasite has emerged
as a robust genetic model, easy to cultivate, efﬁciently transfected
by electroporation (>30%) [54] and amenable to reverse genetic
manipulation [55]. Attempts to optimise transfection by using
other protocols have not resulted in higher efﬁciencies than elec-
troporation with a BTX electroporator [27].
Similar to the Plasmodium species, T. gondii also displays a proﬁle
of transcripts that are tightly regulated during the cell cycle [56].
Therefore, the use of a constitutive promoter, such as the a-tubulin
promoter, can in some circumstances be detrimental for survival
and interfere with proper targeting. Epitope-tagging at an endoge-
nous locus preserved native expression levels and proved to be the
most suitable strategy to assess the level of expression of a gene
and the subcellular localisation of its product. Inconveniently, stable
transformation in T. gondii results primarily in randomintegrationof
the plasmid into the genome, as the parasite is not able to maintain
episomes [54]. Ku80 is implicated in a DNA double-strand break re-
pair mechanism called non-homologous end-joining repair (NHEJ)
and is responsible for the high rate of random integration of trans-
fected DNA. Transfection in DKu80 strain of T. gondii, in which ran-
dom integration is abolished, leads to the production of parasite
mutants resulting almost exclusively from homologous recombina-
tion events [57,58]. This strategy reduces the size of the ﬂanking se-
quences required to 6500 bp [57,59]. Importantly, Ku80 has been
implicated in various additional cellular processes, including chro-
matin maintenance. As a result, the DKu80 strain, which otherwise
behaves the same as wild-type parasites, is more sensitive to dou-
ble-strand DNA breaks [57] and may not be suitable for protocols
that expose the parasite to stresses that can cause such breaks
(e.g., chemical or UV mutagenesis). The T. gondii DKu80 strain be-
haves like the Plasmodium parasites in which genome integration
of DNA occurs mainly by homologous recombination [60]. Consis-
tent with this behaviour, studies of DNA repair mechanisms in var-
ious protozoa showed that the Ku70 and Ku80 proteins are absent
from the Plasmodium genomes [1,28,60]. Homologous recombina-
tion can be used not only for protein tagging by fusion with an epi-
tope tag or a reporter gene but also for disrupting non-essential
genes.
The close relationship between coccidian parasites has been ex-
plored to study the genes from parasites that are resistant to genet-
ic techniques. Eimeria sequences have been expressed in T. gondii
[61] leading to informative trans-genera complementation [62]. In-
versely, there are examples of insightful expression of T. gondii
genes in N. caninum [63] or in P. berghei [64]. A large array of select-
able markers is available in T. gondii, including those markers orig-
inally developed to establish stable transfection, such as DHFR-TS
[65], the bacterial chloramphenicol acetyl transferase (CAT) [66]
and the bleomycin (BLE) selection, which confers resistance to
phleomycin [67,68]. The hypoxanthine-xanthine-guanine phos-
phoribosyl transferase (HXGPRT) gene takes advantage of parasite
Table 1
Examples of reporter genes available in Apicomplexa and their use.
Reporter gene Uses
Fluorescent reporters
gfp/egfp Pf/Pb/Tg Ex: intra vital imaging of parasites [133]
rfp/Dsred/mCherry Pf/Pb/Tg Ex: visualisation of sub-cellular structures such as organelles [139]
yfp Tg Ex: monitoring of protein localisation – FACS sorting [72]
Enzymatic reporters
b-galactosidase Pb Ex: quantiﬁcation of parasite transmission [134]
Tg Ex: assessment of parasite growth under drug treatment [141]
CAT Pf Ex: assessment of transfection efﬁciency [135] – Tg Ex: monitoring parasite growth [66]
luciferase Pb/Tg Ex: visualisation of parasite load and location within live animals [138,140]
High-throughput screening of drugs [136,142]
Analysis of promoter element activities [137]
dual-luciferase Pf/Pb/Tg Renilla and Fireﬂy luciferase co-expressed in the same parasite
Ex: comparison of promoter activities [36]
Selectable markers
Positive Used in/conveying resistance to
HXGPRT Tg/mycophenolic acid [69]
CAT Tg/chloramphenicol [66]
Tgdhfr-ts Tg/Pb/Pf pyrimethamine [37,65]
hdhfr-ts Pb/Pf pyrimethamine, WR99210 [38]
BSD Pf blasticidin [40]
NEO PfG418 [40]
yDHOD Pf atovaquone [43]
BLE Tg phleomycin [67,68]
Negative
CD/UPRT Pf cytosine deaminase/uracil phosphoribosyl transferase [51]
HSV-TK Pf/Pb ganciclovir [50]
HXGPRT Tg 6-thiouridine[70]
YFP Tg/FACS sorting [72]
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sitive and negative selective marker [69,70]. A dual selection can
also be achieved with the salvage enzyme, uracil phosphoribosyl-
transferase (UPRT) [71]. YFP can be used as a negative selectable
marker gene when combined with the ﬂuorescence activated cell
sorting of the recombinant parasites [72]. Furthermore, all these
selectable marker genes can be recycled by applying the Cre/LOX
system [73], and the simultaneous insertion of multiple transgenes
can be achieved by applying restriction enzyme-mediated inser-
tion (REMI) [74].
3. From gene to function
Gene disruption at a speciﬁc locus can be achieved by a double
homologous recombination leading to the replacement of the tar-
geted gene by the cassette expressing the selectable marker gene.
The recovery of parasites that have undergone homologous recom-
bination events has been hindered, particularly in T. gondii, by the
high frequency of random integration. Vectors containing large re-
gions of homologous sequences ranging from 2 to 16 kbp have
been designed to increase the frequency of homologous integration
[66,75,76]. To circumvent the difﬁculties in generating large plas-
mids, the recombineering strategy [77] has been successfully ap-
plied to T. gondii using genomic cosmid libraries (approx. 45 kb)
to generate knockouts [78]. Alternatively, the use of the T. gondii
DKu80 strain has facilitated the recovery of homologous events.
Knockout mutants resulting from single crossovers in the middle
of the gene of interest are easily obtained. One caveat is the revers-
ible nature of this event, which can lead to restoration of the wild-
type locus. Once the non-essentiality of a gene is established, it is
recommended to generate a clean gene disruption by a double
crossover, which is favoured when the 50 and 30 regions for homol-
ogy are free at both ends of the linearised vector. Repeated failures
to obtain an allelic replacement in the T. gondii DKu80 strain or inP. berghei strongly argue for the essentiality of the target gene
[57,79]. In such cases, alternative approaches to identify gene func-
tion are necessary and are discussed below. Phenotype(s) assess-
ment of a mutant obtained by a gene knockout requires
validation by reintroducing a wild-type copy of the gene into the
mutant with resulting rescue of the phenotype. Ideally, the com-
plementing transgene should be driven by its own promoter. In
Plasmodium species, complementation of gene knockouts has not
been performed routinely. Instead, the isolation of two indepen-
dent mutant clones exhibiting the same phenotype has been found
sufﬁciently compelling. In view of the recent improvements in
transfection technology, a request has been made to the malaria
research ﬁeld that complementation of knockout strains should
now become a standard procedure [80].
By focusing on one-by-one gene knockout approaches, laborato-
ries have succeeded in generating large numbers of mutants, with
one study alone in P. falciparum producing and analysing 53 trans-
genic parasites implicated in one aspect of the parasite’s biology
[81].
However, the generation of mutants on such a scale is heroic
and requires a large amount of manpower, making alternative
strategies important.
4. From function to gene
Forward genetics is a powerful approach to identify a single
gene or set of genes implicated in a biological process for which
a given phenotype can be screened or selected. Mutants can either
be natural, selected or induced chemically. N-Nitroso-N-ethylurea
(ENU) is an alkylating agent used to introduce point mutations into
parasite genomes. A key feature of a library is that the mutants
harbour an average of one mutation per genome. If the biological
process to be studied is essential for parasite survival and propaga-
tion, the mutagenesis is followed by the selection of temperature
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Elmer Pfefferkorn in the 1970s [82].
Recently, numerous essential genes implicated in the cell cycle
control of T. gondii have been identiﬁed by the generation of a
ts-library followed by functional complementation based on the
cosmid genomic library [17,83]. Initially, complementation was
performed using cDNA libraries [84,85]; however, this strategy
proved to be limited by the bias of the cDNA library itself, in which
some cDNAs were more abundant than others, and therefore com-
plementation failed to cover all parasite genes. Complementation
of a mutant with a cDNA library requires both a high transfection
efﬁciency and a high frequency of transformation to cover the full
genome. In contrast, a cosmid library offers better coverage of the
genome and a reduction in the number of complemented mutants,
as each cosmid contains more than one gene sequence. Alterna-
tively, the high frequency of random integration in T. gondii has
also been utilised to generate libraries based on insertion muta-
genesis. Such an approach was developed to study the mechanism
governing the conversion between tachyzoites and bradyzoites
[86,87]. In this approach the gene of interest is identiﬁed by plas-
mid rescue.
In contrast, in organisms such as some Plasmodium species in
which genome integration occurs almost exclusively by homolo-
gous recombination, site-speciﬁc transposable elements can be
exploited. The extent of genome coverage depends on the abun-
dance and distribution of the target sites. The ﬁrst shuttle transpo-
son mutagenesis in P. berghei [88] involved Tn5-derived
mutagenesis. This strategy included a step in E. coli that has been
shown to be technically cumbersome. More recently, a piggyBac
transposon, which mediates insertion at TTAA sites throughout
the genome [89], supplanted the previous system. In an attempt
to generate a middle-scale screening based on this strategy, the
authors generated approximately 180 mutants, among which 39
were inserted within gene coding sequences. Although this ap-
proach resulted in a modest yield of genes analysed, one can pre-
dict improvements concomitant with increased transfection
efﬁciency in P. falciparum. Recently, this approach has been suc-
cessfully adapted to P. berghei [90].
Additional limitations are encountered when searching for the
identity of a gene responsible for a phenotype in malaria parasites.
In P. falciparum, due to the low transfection efﬁciency, complemen-
tation has so far not resulted in satisfactory numbers of genes
being identiﬁed in insertion mutant collections [89]. The tremen-
dous improvement in sequencing technologies is a powerful solu-
tion to this problem. For example, genes conferring resistance to
drugs have been identiﬁed by genome-wide high-density tiling
microarrays, DNA sequencing, and copy number variation analysis
of mutant parasites [18].
Chemical genetics has emerged in the last few years as a novel,
potent approach that exploits libraries of small molecules to affect
biological processes and eventually identify the targeted genes. A
high-throughput microscope-based assay was developed to select
compounds interfering with T. gondii motility and invasion [91].
More recently, a small-molecule inhibitor identiﬁed in that screen
was shown to target the myosin light chain 1, a key component of
the gliding machinery conserved in all Apicomplexans [92]. P.
falciparum is also amenable to such a high-throughput approach
as exempliﬁed by a recent phenotypic forward chemical genetic
screen aimed at the discovery of new anti-malarial drugs [93].5. The headache of essential genes
When a gene is essential in the stage of the life cycle that can be
manipulated, a classical gene knockout approach cannot be used to
characterise it. Unravelling the function of an essential gene can beachieved, however, by controlling its expression at several possible
levels. Inducible systems control expression at the transcriptional
level, whereas RNAi or ribozyme-mediated strategies inﬂuence
the expression post-transcriptionally at the level of mRNA stability.
Ultimately, it is also possible to modulate expression post-transla-
tionally at the level of protein stability.
5.1. Control at the transcriptional level
A commonly used methodology to control gene expression is
based on the tetracycline-repressor (TetR) system of E. coli, which
in the Apicomplexans was ﬁrst adapted in T. gondii [94]. The bacte-
rial TetR system can regulate gene expression by interfering with
the initiation of transcription. In this scenario, the tetracycline
operator (tetO) sequences are placed between the cis-acting ele-
ment of the promoter and the site(s) of initiation of transcription.
The binding of the TetR repressor physically interferes with tran-
scription. Upon addition of tetracycline, this interference is allevi-
ated by the release of TetR from the tetO sequences, resulting in
gene expression. The TetR system was further improved in T. gondii
by a fusion between a YFP gene and the bacterial TetRep, which re-
sulted in a 6-fold increase in gene expression compared to that
using TetRep alone [95]. Despite this step up, the need to maintain
parasites under anhydrotetracyclin (Atc) for the generation of con-
ditional mutants was a limitation [96]. In contrast, a system based
on a tetracycline-controlled transactivator (tTA) is one of the most
prominent and widely accepted inducible systems so far. The Tet-
off version allows an inducible expression of a gene of interest,
which can be repressed in the presence of the drug. The tTA con-
sists of a fusion between the tetR and the activating domain of Her-
pes simplex protein VP16. In this system, the gene of interest is
placed under the control of a minimal promoter fused to several
tetO sequences. When introduced into cells expressing the tTA,
gene expression is activated and can be silenced by addition of tet-
racycline. Although the tetR system proved to be functional, a tTA
system failed to work in T. gondii because the activating domain of
VP16 does not interact with the parasite transcription machinery
[94]. A genetic screen based on random insertion of TetR in T.
gondii was performed to generate the transactivators Tati-1 and
Tati-2 and led to the ﬁrst conditional disruption of an essential
gene [97]. This system was adapted to P. falciparum using the
Toxoplasma-derived transactivators, and it allowed regulated
expression of GFP from episomes [98,99]; however, expression
was not robust enough when the transgenes were stably inte-
grated as single copy. To improve the robustness of the system a
more potent activating domain appeared to be necessary. A rudi-
mentary transcription machinery with a very limited number of
transcription factors was initially described in Apicomplexans
[96,100]. The seminal discovery of a family of apicomplexan-spe-
ciﬁc DNA binding proteins, called ApiAP2 (apicomplexan APET-
ALA2) [101], has considerably changed this view. Recent studies
have validated several members of this family as bona ﬁde tran-
scription factors [102,103]. Mapping of the activating domains on
some ApiAP2s allowed the generation of new transactivators fused
to TetRep and called TRADs (TetRep-Activating domains). The
strength and tightness of TRADs as inducible transactivators were
tested in T. gondii and further assessed in P. bergheiwith the reporter
gene integrated as single copy (Pino et al., unpublished). This new
generation of tet-inducible systems has now been validated by dis-
ruption of two essential genes in P. berghei. This technology ﬁlls an
important gap in the tools available for conditional gene expression
in P. berghei and raises hopes for application in P. falciparum.
An elegant alternative strategy for conditional expression has
been developed for P. berghei using a stage-speciﬁc expression of
Flp recombinase to mediate gene deletion [35]. The Cre and Flp
recombinases recognise speciﬁc short DNA sequences (the LOX
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the two sites. The power of the Cre recombinase activity has ham-
pered its utilisation in a controlled fashion [44]. Efforts to develop a
conditional gene targeting approach have therefore focused on
adapting the Flp recombinase, whose activity can be made temper-
ature-sensitive [104]. The FRT sites have been introduced into the
genome by double homologous recombination, ﬂanking the 30 reg-
ulatory sequences of the target gene in a strain expressing the
recombinase. The Flp recombinase gene expression is stage-specif-
ically controlled by the regulatory sequences of genes, such as
Pbuis4, which is expressed in sporozoites only. This strategy results
in the loss of gene expression by removal of the FRT-ﬂanked se-
quence in a stage-speciﬁc manner, such as during the liver stage
in the case of uis4 [35]. Gene essentiality for intraerythrocytic
stages can be established via this strategy, however the pheno-
types cannot be adequately investigated. Signiﬁcantly, the impact
of removing the 30 regulatory sequences on the level of gene
expression is unpredictable and in some circumstances might not
be sufﬁcient to produce a phenotype due to residual expression.
There is signiﬁcant potential to adapt this system to P. falciparum
using temperature shift as a trigger for the conditional expression
of the recombinase [35].
5.2. Control at the post-transcriptional level
The emergence of RNA interference (RNAi) as amethod of choice
for targeting gene expression in various eukaryotes has motivated
several laboratories to try to establish this technology in Apicom-
plexans. Success has been elusive, however, and whether such a
technique is applicable has remained a matter of debate [105]. Fur-
thermore, recent work has highlighted evolutionary differences be-
tween Plasmodium spp. and T. gondii [106]. While previous studies
reported down regulation of gene expression by RNA degradation in
P. falciparum [107–109] and T. gondii [110], compelling evidence
that the effects observed were due to an RNAi-dependent mecha-
nism was lacking. Through a rigorous experimental approach,
Baum et al. ruled out the functionality of RNAi in P. falciparum,
either introducing dsRNA directly into infected red blood cells by
electroporation or by adding siRNAs to the culture medium [106].
Although the uptake of siRNA by P. falciparum could not be demon-
strated, electroporation of P. berghei parasites with siRNA using the
Amaxamethod also failed to lead to silencing. Comparative genom-
ics (Hidden Markow models) and phylogenetic approaches were
applied to search for structurally related but potentially highly
divergent homologues to RNAi machinery-related genes in P.
falciparum. However, no homologues for Dicer and Argonaute have
been found in malaria parasites although these genes are present in
T. gondii [106]. Furthermore, components of RNA-induced silencing
complexes (RISCs) have been identiﬁed in T. gondii by mass spec-
trometry as interactingwith TgAGO andmiRNAs [111]. The absence
of retrotransposons and viruses in P. falciparum and T. gondii gen-
omes is consistent with the role of RNAi inmediating gene silencing
of transposable elements and in ﬁghting against virus invasion
[112,113]. Interestingly, no endogenous miRNAs have been de-
tected in P. falciparum [114,115], while a complex set of miRNAs
has been described in T. gondii, consistent with the presence of
the RNAi enzymology [111]. Despite the presence of key players
in RNAimachinery in T. gondii, its utilisation as a tool to silence gene
expression has remained marginal. Antisense RNAs can also dra-
matically drop the levels of corresponding sense RNAs in an
RNAi-independent fashion. Interestingly, P. falciparum harbours
abundant levels of endogenous antisense transcripts [116]; how-
ever, the antisense approach does not appear to modulate gene
expression reliably in this parasite [106].
An alternative method to regulate gene expression at the mRNA
level has been reported for T. gondii using ribozyme-mediateddown regulation of the targeted mRNA [117]. Suppression of gene
expression can be achieved by adding an 85 bp sequence coding for
a hammerhead ribozyme and positioned upstream of the start co-
don of the endogenous locus. Gene expression can be partially res-
cued upon addition of toyocamycin, an adenosine analogue
inhibitor of hammerhead activity [118]. The main limitation of this
strategy appears to be the toxicity of toyocamycin for the parasites.
Deletion of the parasite adenosine kinase activity, known in mam-
malian cells to participate in the toxic effect, conferred resistance
to the drug; however, the regulation of the ribozyme was simulta-
neously lost [117].
5.3. Control at the level of protein stability
A fast response strategy known as the ‘‘destabilisation domain
(DD) system’’ has been recently developed to control gene expres-
sion at the level of protein stability in mammalian cells [119].
When fused to the target protein, the FK506-binding protein deg-
radation domain (ddFKBP) dramatically interferes with protein sta-
bility, resulting in rapid degradation of the protein by the
proteasome. Rescue of protein stability can be achieved by adding
a rapamycin-derived ligand called shield (shld-1), which speciﬁ-
cally interacts with the ddFKBP, folds it and blocks degradation
[119]. The reversible and rapid nature of this process makes it very
appealing for controlling gene expression conditionally, and it has
been reported to work in both T. gondii and P. falciparum [120,121].
This system allows the conditional degradation of a vital protein at
a speciﬁc time and the investigation of its function. Such an allelic
replacement, leading to a ddFKBP fusion with an endogenous pro-
tein, has been reported in P. falciparum [122,123], but has also
highlighted the limitations of the system primarily due to the tox-
icity of the shield that needs to be permanently provided in the
culture. Moreover the system has not worked satisfactorily in P.
berghei possibly due to the poor bioavailability in vivo. More
attractively, this system provides an exquisite approach to control
the expression of dominant negative mutants or toxic genes. Pro-
teins well suited for the generation of dominant negative mutants
include the Rab family of GTPases and dynamins [124–127] as well
as proteins acting as part of a complex or as homodimers, such as
the formins [128]. Other catalytically inactive enzymes can also act
as dominant negative mutants by sequestering their substrates
[129].
The destabilisation domain works optimally when positioned at
the N-terminus of the target protein and hence is not well suited
for proteins harbouring a signal peptide and targeted to the secre-
tory pathway. However, some polytopic proteins such as the rhom-
boid proteases, which exhibit an N-terminal cytosolic tail, respond
well to destabilisation [129].
This approach remains suboptimal for generating conditional
knockouts because shld-1 must be continuously present in the par-
asites. Currently, the cost of shld-1 is prohibitive and, more impor-
tantly, the compound is associated with toxicity in long-term
experiments [122]. Moreover, the bioavailability of shld-1 might
constitute a limitation for applications in P. berghei, although the
ligand has been administrated successfully to mice [130]. A con-
ceptually similar approach, based on another degradation domain
has recently been reported for mammalian cells [131] and adapted
successfully to P. falciparum [29]. This method overcomes the pre-
viously mentioned drawbacks. The system is based on a mutant of
the E. coli dihydrofolate reductase (ecDHFR) engineered to be de-
graded and called the DHFR degradation domain (DDD). The DDD
can be stabilised using trimethoprim (TMP), an inexpensive folate
analogue [131]. DDD has been combined with a ﬂuorescent marker
and an epitope-tag to generate a so-called regulatable ﬂuorescent
afﬁnity (RFA) tag that can be studied either episomally or after tag-
ging at an endogenous locus [29]. The rapid, reversible stabilisation
Fig. 1. Summary of the available tools for gene manipulation in Apicomplexan parasite. Scheme representing the available tools for each parasite: T. gondii in red, P.
falciparum in green, P. berghei in blue, as well as in the intersecting sectors the tools shared between more than one parasite. The white sector in the centre contains the tools
established in all three models.
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(50–100 nM) is comparable to the dynamics observed with ddFKBP
fusions; however, DDD requires working with P. falciparum strains
containing a human DHFR (hDHFR) marker to alleviate the natural
toxicity of TMP for the parasite [29]. The strong inhibition by TMP
of ecDHFR compared to hDHFR, in addition to the good pharmaco-
logical properties of the compound (e.g., crossing the blood–brain
and placental barriers) proved to be suitable for studies on mam-
malian systems [131]. This raises hopes for its application to P.
berghei. Adaptation of either the Tet-system, ddFKBP or DDD tech-
niques to conditional knockout approaches in the vector and liver
stages of P. berghei still represent a signiﬁcant challenge in term of
accessibility of the inducers.
6. Concluding remarks
The research community has dedicated tremendous and inno-
vative efforts to overcoming the multiple barriers encountered
when analysing gene function in apicomplexan parasites. A
scheme summarising the available tools for gene manipulation
that have been tailored to the speciﬁc feature of each parasite is
presented in Fig. 1. A combination of the technologies recently
established and their adaptation to genome wide approaches can
now be envisioned. Along these lines, the high random integration
frequency in T. gondii has recently been elegantly adapted to direct
insertion events by a promoter trap with a drug-selectable marker
and to concomitantly substitute the promoter of the trapped gene
with a conditional Tet-transactivator promoter [132].
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